abs431.txt	purpose		as	massively	parallel	sequencing	is	increasingly	being	used	for	clinicaldecision	making	it	has	become	critical	to	understand	parameters	that	affectsequencing	quality	and	establish	methods	measuring	reporting	clinicalsequencing	standards	in	this	report	we	propose	a	definition	reducedcoverage	regions	describe	set	of	variant	calling	applications	enable	centers	assess	the	poor	sequencingquality	their	own	data	optimized	tool	(excid)	identifyreduced	coverage	loci	within	genes	or	particular	interest	usedthis	framework	examine	from	500	patients	generated	10projects	at	national	human	genome	researchinstitute/national	cancer	institute	clinical	exploratory	researchconsortium	results	approach	identified	reduced	clinically	relevantgenes	including	known	relevant	were	uniquely	missed	atindividual	multiple	all	conclusion	provides	process	road	map	sequencingcenters	looking	perform	similar	analyses	on
